This algorithm suggests a different threshold of serum HBV DNA and alanine aminotransferase (ALT) levels for the initiation of treatment and recommends a broader role for the use of liver biopsy, especially in patients > 35 to 40 years of age with normal ALT levels. UpToDate also includes ...